Mobile

A study to measure pretection (antibody response) and safety against representative strains causing a high proportion of disease (Meningococcal Group B) in healthy subject aged between 12 and <19 year...

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-003822-42

A study to measure pretection (antibody response) and safety against representative strains causing a high proportion of disease (Meningococcal Group B) in healthy subject aged between 12 and <19 years

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Primary Immunogenicity Objective • To describe the immune response, relative to baseline status, following receipt of Bexsero as measured by hSBA performed with a panel of MnB test strains assessed 1 month after the second vaccination with Bexsero vaccine. Primary Safety Objective • To describe local reactions and systemic events following receipt of Bexsero vaccine.

Critère d'inclusion

  • Test the safety and immunogenicity of Bexsero used as a vaccine for Neisseria meningitidis

Liens